Intraoperative blood salvage HCC management remains a contentious topic among transplant surgeons and anesthesiologists. While autotransfusion effectively reduces the need for allogenic blood, many clinicians fear it might inadvertently spread malignant cells. This concern often limits the use of blood conservation techniques in patients with hepatocellular carcinoma (HCC) undergoing liver transplantation.

Safety of Intraoperative Blood Salvage HCC in Transplantation

A recent retrospective study examined 245 adults who underwent deceased donor liver transplantation between 2007 and 2020. Specifically, the researchers compared outcomes between patients who received intraoperative blood salvage and those who did not. Interestingly, the study did not utilize leukodepletion filters during the autotransfusion process. The results clearly demonstrated that the use of salvaged blood was not associated with a decrease in the time to HCC recurrence.

Notably, the primary outcome showed a hazard ratio of 0.80 for the autotransfusion group, indicating no statistically significant risk. Furthermore, secondary outcomes like recurrence-free survival and overall survival remained comparable between both cohorts. Instead of the transfusion method, independent predictors of recurrence included Hepatitis C infection, the total number of lesions, and the size of the largest tumor. Consequently, these findings suggest that tumor biology and pre-existing conditions play a far more critical role in recurrence than intraoperative blood management.

Overall, this data provides reassurance to surgical teams across India and beyond. By implementing autotransfusion, clinicians can mitigate the risks of allogenic blood while maintaining oncological safety. Therefore, the use of intraoperative blood salvage appears to be a viable and safe strategy for managing hemorrhage during complex liver transplants in HCC patients.

Frequently Asked Questions

Does intraoperative blood salvage increase cancer recurrence?

No, this study found no evidence that intraoperative blood salvage or autotransfusion increases the risk or speed of HCC recurrence after liver transplantation.

Are leukodepletion filters mandatory for safe autotransfusion in HCC?

While often discussed, this specific study observed safe outcomes even without the use of leukodepletion filters, suggesting the technique is inherently safer than previously feared.

What are the actual risk factors for HCC recurrence?

The study identified Hepatitis C, a higher number of tumor lesions, and larger tumor size as the primary independent predictors for cancer recurrence post-transplant.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional opinion. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Butler EV et al. Hepatocellular Cancer Recurrence After Liver Transplantation With and Without the Use of Intraoperative Blood Salvage and Autotransfusion: A Retrospective Study. Anesth Analg. 2026 Mar 20. doi: 10.1213/ANE.0000000000007998. PMID: 41860585.

Ivanics T, et al. Blood Cell Salvage and Autotransfusion Does Not Worsen Oncologic Outcomes Following Liver Transplantation with Incidental Hepatocellular Carcinoma: A Propensity Score-Matched Analysis. Ann Surg Oncol. 2021;28(12):7849-7859.

Li J, et al. Safety of cell saver use in liver transplantation for hepatocellular carcinoma. World J Gastroenterol. 2022;28(15):1567-1578.